JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB101282

Anti-UBN1 antibody

Be the first to review this product! Submit a review

|

(5 Publications)

Rabbit Polyclonal UBN1 antibody. Suitable for WB and reacts with Human samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human UBN1 aa 1050 to C-terminus.

View Alternative Names

Ubinuclein-1, HIRA-binding protein, Protein VT4, Ubiquitously expressed nuclear protein, UBN1

6 Images
Western blot - Anti-UBN1 antibody (AB101282)
  • WB

Unknown

Western blot - Anti-UBN1 antibody (AB101282)

All lanes:

Western blot - Anti-UBN1 antibody (ab101282) at 0.1 µg/mL

Lane 1:

HeLa whole cell lysate at 50 µg

Lane 2:

HeLa whole cell lysate at 15 µg

Lane 3:

HeLa whole cell lysate at 5 µg

Lane 4:

293T whole cell lysate at 50 µg

Predicted band size: 122 kDa

true

Exposure time: 3min

Western blot - Anti-UBN1 antibody (AB101282)
  • WB

CiteAb

Western blot - Anti-UBN1 antibody (AB101282)

Western Blotting using Anti-UBN1 antibody, ab101282. Publication image from Ray-Gallet, D. et al., 2018, Nat Commun, 30082790. Legend direct from paper.

HIRA homooligomerizes in cells and forms a homotrimer in vitro. a YFP constructs of human HIRA and mutants. The WD40 repeat (aa 1–369), B (aa 439–475) and C (aa 763–963) domains involved in UBN, ASF1a, and CABIN1 interactions, respectively, are shown. Star indicates single amino acid substitution with alanine. The co-immunoprecipitation efficiency of endogenous HIRA or HIRA-HA (HIRA coIP) is indicated for each construct, “+” indicates that the efficiency of coIP is similar to the one obtained with the wt HIRA construct and “−” indicates that the efficiency of the coIP is decreased. b Western blot analysis of anti-GFP-immunoprecipitates from U2OS nuclear extracts expressing YFP-tagged proteins. c Western blot analysis of anti-GFP-immunoprecipitates from U2OS nuclear extracts expressing both YFP-tagged and HIRA-HA proteins. d Western blot analysis of anti-GFP-immunoprecipitates from U2OS nuclear extracts expressing YFP-tagged proteins. In b, c and d, input corresponds to 10% of nuclear extract used for each experiment. e Equilibrium sedimentation of recombinant proteins HIRA(661–1017), CABIN1 full length (FL) and HIRA(661–1017) + CABIN1 FL. Theoretical (open symbols) and experimental (closed symbol) curves are shown

false

Western blot - Anti-UBN1 antibody (AB101282)
  • WB

CiteAb

Western blot - Anti-UBN1 antibody (AB101282)

Western Blotting using Anti-UBN1 antibody, ab101282. Publication image from Ray-Gallet, D. et al., 2018, Nat Commun, 30082790. Legend direct from paper.

HIRA homooligomerization is required for CABIN1 interaction. a YFP constructs of human HIRA and mutants. The amino acids R227 and I461 critical for UBN and ASF1a interactions, respectively, are shown. Star indicates single amino acid substitution (R227 with K or I461 with D). The co-immunoprecipitation efficiencies of both endogenous HIRA (HIRA coIP) and CABIN1 (CABIN1 coIP) are indicated for each construct, “+” indicates that the efficiency of coIP is similar to the one obtained with the wt HIRA construct and “−” indicates that the efficiency of the coIP is decreased. b Western blot analysis of anti-GFP-immunoprecipitates from U2OS nuclear extracts expressing YFP-tagged proteins. c Western blot analysis of anti-GFP-immunoprecipitates from U2OS nuclear extracts expressing both HIRA-YFP and HIRA-HA proteins prepared from cells treated with siRNAs control or CABIN1. In b and c, input corresponds to 10% of nuclear extract used for each experiment

false

Western blot - Anti-UBN1 antibody (AB101282)
  • WB

CiteAb

Western blot - Anti-UBN1 antibody (AB101282)

Western Blotting using Anti-UBN1 antibody, ab101282. Publication image from Ray-Gallet, D. et al., 2018, Nat Commun, 30082790. Legend direct from paper.

HIRA homooligomerization is required for CABIN1 interaction. a YFP constructs of human HIRA and mutants. The amino acids R227 and I461 critical for UBN and ASF1a interactions, respectively, are shown. Star indicates single amino acid substitution (R227 with K or I461 with D). The co-immunoprecipitation efficiencies of both endogenous HIRA (HIRA coIP) and CABIN1 (CABIN1 coIP) are indicated for each construct, “+” indicates that the efficiency of coIP is similar to the one obtained with the wt HIRA construct and “−” indicates that the efficiency of the coIP is decreased. b Western blot analysis of anti-GFP-immunoprecipitates from U2OS nuclear extracts expressing YFP-tagged proteins. c Western blot analysis of anti-GFP-immunoprecipitates from U2OS nuclear extracts expressing both HIRA-YFP and HIRA-HA proteins prepared from cells treated with siRNAs control or CABIN1. In b and c, input corresponds to 10% of nuclear extract used for each experiment

false

Western blot - Anti-UBN1 antibody (AB101282)
  • WB

CiteAb

Western blot - Anti-UBN1 antibody (AB101282)

Western Blotting using Anti-UBN1 antibody, ab101282. Publication image from Ray-Gallet, D. et al., 2018, Nat Commun, 30082790. Legend direct from paper.

Homotrimerization of HIRA is critical for its enrichment at UV damaged sites and for new H3.3 deposition. a (Left, top) Scheme of the experimental assay for HIRA-YFP enrichment at local UV damage in U2OS cells. (Left, bottom) The graph shows the percentage of U2OS cells with HIRA-YFP protein colocalizing with XPB foci. Error bars represent SD from three independent experiments. Statistical analysis using a t-test was performed with Prism 7 software (ns : nonsignificant, *p < 0.05, ***p < 0.001). (Right) Images of representative U2OS cells irradiated locally with UV exhibiting an enrichment of HIRA wt or an absence of enrichment of HIRA (W799A–D800A) at one damage site identified by anti-XPB immunofluorescence. Scale bar 5 µm. b (Top, left) Scheme of the experimental assay for new H3.3 deposition by a Quench-Chase-Pulse experiment (QCP) in HeLa H3.3-SNAP-HA HIRA KO cells transfected with HIRA-HA constructs. (Top, right) Western blot analysis showing the protein expression of exogeneous HIRA-HA wt and (W799A–D800A) mutant. (Bottom, left) Images of cells subjected to QCP : representative images for a cell non-transfected or transfected with HIRA-HA (W799A–D800A) mutant and a high TMR positive representative image for a cell transfected with HIRA-HA wt. (Bottom, right). One graph shows the fluorescence intensity ratio TMR/TMR non-transfected. The other graph gives the percentage of cells exhibiting a positive profile for H3.3 deposition. Error bars represent the SD from three independent experiments. Statistical analysis using a t-test was performed with Prism 7 software (ns : nonsignificant, *p < 0.05)

false

Western blot - Anti-UBN1 antibody (AB101282)
  • WB

CiteAb

Western blot - Anti-UBN1 antibody (AB101282)

Western Blotting using Anti-UBN1 antibody, ab101282. Publication image from Ray-Gallet, D. et al., 2018, Nat Commun, 30082790. Legend direct from paper.

Domains of HIRA involved in its homooligomerization and CABIN1 interaction are distinct. a YFP constructs of human HIRA and mutants. Three different structures matching the previously described C domain are indicated : β-strand (aa 661–872), loop (aa 873–904) andα-helical (aa 905–1017) domains. Star indicates single amino acid substitution with alanine. The co-immunoprecipitation efficiency of endogenous CABIN1 (CABIN1 coIP) is indicated for each construct, “+” indicates that the efficiency of coIP is similar to the one obtained with the wt HIRA construct and “−” indicates that the efficiency of the coIP is decreased. b Western blot analysis of anti-GFP-immunoprecipitates from U2OS nuclear extracts expressing YFP-tagged proteins. Input corresponds to 10% of nuclear extract used for each experiment. c (Left) Western blot analysis of nuclear extracts from HIRA KO and control HeLa cells. (Right) Western blot analysis of nuclear extracts from HeLa HIRA KO cells expressing YFP-tagged proteins. d Superose 6 fractionation of recombinant proteins CABIN1 FL, CABIN1 FL + HIRA(661–1017) and CABIN1 FL + HIRA(661–1017) δ873–904. The dashes indicate the fractions in which free CABIN1 FL elutes. Input corresponds to protein at the concentration that it was loaded onto the Superose 6 column. e Equilibrium sedimentation of recombinant protein HIRA(661–1017) δ873–904. Theoretical (open symbols) and experimental (closed symbol) curves are shown

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human UBN1 aa 1050 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q9NPG3

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000 - 1/10000", "WB-species-notes": "<p></p>" }, "Chimpanzee": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Gorilla": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rhesus monkey": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab101282 was affinity purified using an epitope specific to UBN1 immobilized on solid support.
Storage buffer
pH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: Tris citrate/phosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

UBN1 also known as Ubinuclein-1 plays an important role at the mechanical level in remodeling chromatin structure. It has a mass of approximately 83 kDa. This protein is found predominantly in the nucleus and is widespread across different tissues particularly in tissues with higher cellular turnover. UBN1 works by interacting with other chromatin-associated proteins such as histones to facilitate chromatin alterations that are necessary for various cellular processes.
Biological function summary

UBN1 acts as a participant in the regulation of gene expression. It is a component of the Human Histone Acetyltransferase complex (HBO1 complex) which modifies chromatin by adding acetyl groups to histones enabling a more open chromatin state. This more open state is important for gene transcription and DNA replication. UBN1's role in this complex is significant for the regulation of genes important for cell cycle progression and other essential cellular functions.

Pathways

Various control processes converge at UBN1. It plays a significant role in the epigenetic pathway influencing gene expression through chromatin modification. UBN1 is involved in the DNA replication initiation pathway where it facilitates the assembly of pre-replicative complexes. In these pathways UBN1 is related to proteins such as MCM2-7 which are essential for unwinding DNA during replication.

Aberrant UBN1 activity has been linked to cancer and neurodevelopmental disorders. In cancer dysregulated expression of UBN1 can lead to improper gene regulation contributing to uncontrolled cell growth and proliferation. UBN1 interacts with proteins like c-Myc in oncogenic pathways. Additionally changes in UBN1 function have been associated with neurodevelopmental disorders through its influence on chromatin dynamics affecting genes essential for brain development.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acts as a novel regulator of senescence. Involved in the formation of senescence-associated heterochromatin foci (SAHF), which represses expression of proliferation-promoting genes. Binds to proliferation-promoting genes. May be required for replication-independent chromatin assembly.
See full target information UBN1

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Cell reports 43:114964 PubMed39509271

2024

HIRA protects telomeres against R-loop-induced instability in ALT cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Michelle Lee Lynskey,Emily E Brown,Ragini Bhargava,Anne R Wondisford,Jean-Baptiste Ouriou,Oliver Freund,Ray W Bowman,Baylee A Smith,Santana M Lardo,Sandra Schamus-Hayes,Sarah J Hainer,Roderick J O'Sullivan

Nature structural & molecular biology 27:1152-1164 PubMed33046907

2020

Regulation of ALT-associated homology-directed repair by polyADP-ribosylation.

Applications

Unspecified application

Species

Unspecified reactive species

Song My Hoang,Nicole Kaminski,Ragini Bhargava,Jonathan Barroso-González,Michelle L Lynskey,Laura García-Expósito,Justin L Roncaioli,Anne R Wondisford,Callen T Wallace,Simon C Watkins,Dominic I James,Ian D Waddell,Donald Ogilvie,Kate M Smith,Felipe da Veiga Leprevost,Dattatreya Mellacharevu,Alexey I Nesvizhskii,Jianfeng Li,Dominique Ray-Gallet,Robert W Sobol,Genevieve Almouzni,Roderick J O'Sullivan

Nature structural & molecular biology 27:1057-1068 PubMed32895554

2020

Two HIRA-dependent pathways mediate H3.3 de novo deposition and recycling during transcription.

Applications

Unspecified application

Species

Unspecified reactive species

Júlia Torné,Dominique Ray-Gallet,Ekaterina Boyarchuk,Mickaël Garnier,Patricia Le Baccon,Antoine Coulon,Guillermo A Orsi,Geneviève Almouzni

Nature communications 9:3103 PubMed30082790

2018

Functional activity of the H3.3 histone chaperone complex HIRA requires trimerization of the HIRA subunit.

Applications

Unspecified application

Species

Unspecified reactive species

Dominique Ray-Gallet,M Daniel Ricketts,Yukari Sato,Kushol Gupta,Ekaterina Boyarchuk,Toshiya Senda,Ronen Marmorstein,Geneviève Almouzni

Molecular endocrinology (Baltimore, Md.) 29:1426-39 PubMed26305679

2015

Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-Terminus.

Applications

Unspecified application

Species

Unspecified reactive species

Alicia M Blessing,Sathya Ganesan,Kimal Rajapakshe,Ying Ying Sung,Lakshmi Reddy Bollu,Yan Shi,Edwin Cheung,Cristian Coarfa,Jeffrey T Chang,Donald P McDonnell,Daniel E Frigo
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com